Valuation: Optimax Holdings

Market Cap 283M 69.59M 60.1M 56.55M 51.4M 96.67M 6.67B 98.09M 663M 260M 3.33B 261M 256M 11.11B P/E 2026 *
18.2x
P/E 2027 * 16.1x
Enterprise Value 279M 68.83M 59.44M 55.93M 50.83M 95.61M 6.59B 97.01M 656M 257M 3.3B 258M 253M 10.99B EV / Sales 2026 *
1.84x
EV / Sales 2027 * 1.72x
Free-Float
23.9%
Yield 2026 *
3.04%
Yield 2027 * 3.54%
05-25 Maybank Research Downgrades Optimax Holdings to Hold from Buy; Price Target is MYR0.58 MT
05-22 Optimax Holdings Berhad Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
03-03 Optimax to Start Offering ENT Services Following Malaysian Health Ministry's Nod MT
03-02 Optimax Holdings Berhad Receives Approval from Ministry of Health to Offer Otorhinolaryngology (Ear, Nose and Throat) Services CI
02-27 Optimax Holdings Berhad Announces Second Interim Single-Tier Dividend on Ordinary Share, Payable 30 March 2026 CI
02-26 Optimax Holdings Berhad Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 CI
11-26 Optimax Holdings Berhad Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 CI
11-26 Optimax Holdings Berhad Announces Interim Single-Tier Dividend for the Year Ended 31 December 2025, Payable on 26 December 2025 CI
08/10/25 Hong Leong Investment Bank Starts Optimax Holdings at Buy with 0.96 Ringgit Price Target MT
26/08/25 Optimax Holdings Berhad Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 CI
28/05/25 Optimax Holdings Berhad Reports Earnings Results for the First Quarter Ended March 31, 2025 CI
27/02/25 Optimax Holdings Berhad Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2024 CI
27/02/25 Optimax Holdings Berhad Announces Interim Single-Tier Dividend for the Year Ended 31 December 2024, Payable on 28 March 2025 CI
1 week-0.95%
1 month-0.95%
3 months-4.59%
6 months-11.86%
Current year-9.57%
1 week 0.51
Extreme 0.51
0.52
1 month 0.51
Extreme 0.51
0.53
Current year 0.5
Extreme 0.505
0.64
1 year 0.5
Extreme 0.505
0.72
3 years 0.46
Extreme 0.46
0.74
5 years 0.46
Extreme 0.46
0.84
10 years 0.3
Extreme 0.305
0.94
Manager TitleAgeSince
Chief Executive Officer 37 30/11/2019
Director of Finance/CFO 38 31/08/2018
Chief Operating Officer 37 31/12/2023
Director TitleAgeSince
Director/Board Member 70 08/08/2018
Director/Board Member 37 30/11/2019
Director/Board Member 44 21/01/2020
Date Insider Type Main position Quantity % Market Cap.
18/04/25
Sena Healthcare Services Sdn. Bhd.
BuyCompany 674,000 0.1241%
11/04/25
Sena Healthcare Services Sdn. Bhd.
BuyCompany 1,014,000 0.1866%
09/04/25
Sena Healthcare Services Sdn. Bhd.
BuyCompany 355,700 0.0655%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-0.95%-11.11%-28.28% 69.59M
+0.96%+1.51%+35.26%+42.06% 121B
+1.67%+0.07%+4.60%+53.04% 89.14B
+0.31%-0.53%+32.02%+76.97% 26.08B
+0.34%+2.11%-5.91%-9.43% 22.03B
+2.14%+4.15%+57.71%+282.30% 21.76B
-0.85%-1.09%-14.13%+10.32% 13.72B
+0.18%-0.59%-5.21%-7.49% 12.5B
+0.68%-0.24%+33.52%+75.18% 11.35B
0.00%+15.38%+152.10%+2,172.73% 10.28B
Average +0.54%+1.73%+27.88%+266.74% 32.83B
Weighted average by Cap. +0.99%+1.25%+25.39%+124.91%

Financials

2026 *2027 *
Net sales 152M 37.41M 32.31M 30.4M 27.63M 51.97M 3.58B 52.73M 357M 140M 1.79B 140M 137M 5.97B 157M 38.76M 33.48M 31.5M 28.63M 53.85M 3.71B 54.64M 370M 145M 1.86B 146M 142M 6.19B
Net income 15.65M 3.86M 3.33M 3.13M 2.85M 5.36M 369M 5.43M 36.76M 14.4M 185M 14.48M 14.16M 615M 17.6M 4.34M 3.74M 3.52M 3.2M 6.02M 415M 6.11M 41.33M 16.2M 208M 16.28M 15.92M 692M
Net Debt -3.1M -764K -660K -621K -564K -1.06M -73.16M -1.08M -7.28M -2.85M -36.59M -2.87M -2.8M -122M -12.4M -3.05M -2.64M -2.48M -2.26M -4.24M -293M -4.31M -29.11M -11.41M -146M -11.47M -11.22M -488M
Logo Optimax Holdings
Optimax Holdings Berhad is a Malaysia-based investment holding company offering eye specialist services. It has approximately seven satellite clinics/centers, 13 ambulatory care centers, one specialist hospital, and 288 staff/professional doctors. Its geographical segments include North Malaysia, Central Malaysia, South Malaysia, East Malaysia, and Cambodia. Its services are categorized into Refractive Surgery, Treatment of Eye Diseases and Disorders, Consultation and Dispensary Services, Oculoplastic Surgery, Plastic Surgery, and Aesthetic Services. Refractive Surgery includes laser and implant vision correction procedures. Treatment of Eye Diseases and Disorders includes cataract surgery and other medical interventions. Consultation and Dispensary Services cover doctor consultations and medication dispensing. Oculoplastic Surgery provides functional and cosmetic treatments around the eye. Its additional services include Eye Examinations, Sales of Optical Wear, and Laboratory Tests.
Employees
-
Date Price Change Volume
19/08/26 MYR 0.5200 0.00% 236,900
18/08/26 MYR 0.5200 0.00% 284,500
17/08/26 MYR 0.5200 0.00% 263,200
14/08/26 MYR 0.5200 0.00% 29,200
13/08/26 MYR 0.5200 -0.95% 153,000
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
0.5200MYR
Average target price
0.6880MYR
Spread / Average Target
+32.31%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 0222 Stock